DOM In the News
Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.
Coronavirus cases are rising again in the Bay Area. Here’s what that means
San Francisco Chronicle |
Monica Gandhi and George Rutherford were quoted in the SF Chronicle about the uptick in coronavirus cases, describing the need to balance the risks of widespread gatherings with the impacts on mental wellbeing.
Whoever wins the presidency, UCSF doctor has advice for tackling Covid-19
SF Gate |
Bob Wachter was quoted in the SF Gate advising the next president to tackle Covid-19 by focusing on mask wearing and creating a testing strategy.
S.F. contact tracing reached more than 80% of patients in the spring
San Francisco Chronicle |
Michael Reid was quoted in the SF Chronicle about the relative success of the San Francisco contract tracing model despite shortcomings, including access to testing and time lags in reaching individuals at risk of infection.
One-On-One With Dr. Bob Wachter, Head of Department of Medicine at UCSF
NBC Bay Area |
Bob Wachter was interviewed on NBC Bay Area giving his medical insights on the coronavirus pandemic and providing guidance on how people can stay vigilant.
S.F.’s coronavirus positive test rate is the lowest of all big U.S. cities. Can it stay that way?
San Francisco Chronicle |
Charles Chiu, Peter Chin-Hong, and Bob Wachter were quoted in the SF Chronicle citing a coordinated effort among city health officials and local experts as a key to keeping the pandemic from spiraling out of control.
Can SF survive the fall Covid-19 surge? UCSF doctor responds
SF Gate |
Bob Wachter was quoted in SF Gate explaining how he believes San Francisco can survive a third wave based on how the city has responded to the virus since the start of the pandemic.
The Health 202: Hundreds of millions of coronavirus vaccine doses will be ready in early 2021, officials say
Washington Post |
Bob Wachter was quoted in the Washington Post commending the Trump administration for its vaccine development efforts.
Will you get a coronavirus vaccine? Many don’t trust it, and low vaccination levels could hinder pandemic recovery
San Francisco Chronicle |
Bob Wachter was quoted in the SF Chronicle about how he believes more people are likely to get a coronavirus vaccine than what the polls currently show.
Diane Havlir challenged the dogma on HIV treatment. Now she’s taking on Covid-19.
Mission Local |
Diane Havlir was featured in a Mission Local l article describing her relentless research and alliance with Mission district community leaders to reduce covid transmissions in the Latinx community, where positivity rates remain higher than the rest of the city’s population.
Bay Area seniors struggle with loneliness as pandemic drags on: ‘It’s four walls and a TV’
San Francisco Chronicle |
Louise Aronson was quoted in the SF Chronicle explaining how older adults may be struggling with loneliness as the pandemic continues.
Despite small surge, Bay Area coronavirus case numbers pale compared to soaring national outbreak
San Francisco Chronicle |
Bob Wachter was quoted in the SF Chronicle describing how there would be far fewer Covid deaths if the country followed San Francisco’s measured approach.
How San Francisco became a Covid-19 success story as other cities stumbled
Los Angeles Times |
Bob Wachter was quoted in a LA Times article about what San Francisco did right to become the first urban city in California to enter the least restrictive tier for reopening.
UCSF Grand Rounds: Wisconsin frontline updates and weighing risks in the third wave of the pandemic
Mission Local |
Bob Wachter and George Rutherford were featured in a Mission Local article regarding the Medicine Grand Rounds discussion on Wisconsin's frontline updates and risk in the third wave of the pandemic.
FDA makes Gilead’s remdesivir the first approved coronavirus treatment drug in the U.S.
San Francisco Chronicle |
Peter Chin-Hong was quoted in the SF Chronicle about recent studies on remdesivir after the federal government approved its use on hospitalized Covid-19 patients.
Unprecedented vaccine trials on track to begin delivering results
Washington Post |
Bob Wachter was quoted in The Washington Post describing how there may be a vaccine that is proven safe and effective in the upcoming months because of strong and effective federal action.